Orthopedic Planning Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
Projected Market Value (2031): US$ 158.2 Mn
Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

What are the key drivers propelling the growth of the orthopedic planning systems market?
What emerging trends are shaping the landscape of orthopedic planning systems?
What are the primary challenges hindering market expansion, and how can they be mitigated?
What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

Formus Labs Ltd,
EOS imaging,
Brainlab AG,
Sectra AB,
Stryker,
Materialise,
Medstrat,
mediCAD Hectec GmbH,
3D Systems, Inc.,
PEEK HEALTH S.A,
Radlink, Inc.,
SurgiNovi,
RSA Biomedical,
HIPOP-PLAN,
Zimmer Biomet,
Optinav,
Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

Web Based Software
Cloud Based Software
On Premises

Orthopedic Planning Systems Market by End User:

Hospitals
Ambulatory Surgical Centers
Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

North America Orthopedic Planning Systems Market
Latin America Orthopedic Planning Systems Market
Europe Orthopedic Planning Systems Market
South Asia Orthopedic Planning Systems Market
East Asia Orthopedic Planning Systems Market
Oceania Orthopedic Planning Systems Market
Middle East & Africa Orthopedic Planning Systems Market

Product Code: PMRREP26182

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Market Background

4.1. Macro-Economic factors
- 4.1.1. Global Healthcare Market Outlook
- 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
- 4.1.3. U.S. per-Capita Healthcare Expenditure
4.2. Forecast Factors
- 4.2.1. Evaluation of Incremental Costs and Effectiveness
- 4.2.2. Increasing Spending on Healthcare Per Capita
- 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
- 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
4.3. Market Dynamics
- 4.3.1. Demand
- 4.3.2. Restraints
- 4.3.3. Opportunity
4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

5.1. Current COVID19 Statistics and Probable Future Impact
5.2. COVID19 and Impact Analysis
- 5.2.1. By Solution
- 5.2.2. By Application
- 5.2.3. By Deployment
- 5.2.4. By End User

6. Key Success Factors

6.1. Key Developments
6.2. Regulatory Scenario
6.3. Key Deals and Contracts
6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

7.1. Country-wise & Regional Pricing Analysis, By Solution
7.2. Pricing Break-up
- 7.2.1. Manufacturer Level Pricing
- 7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
- 8.2.1. Y-o-Y Growth Trend Analysis
- 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
- 9.3.1. Orthopedic Planning Systems
  - 9.3.1.1. Pre-Surgical Planning Software
    - 9.3.1.1.1. 2D Planning Software
    - 9.3.1.1.2. 3D Planning Software
  - 9.3.1.2. Post-Surgical Planning Software
9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 10.3.1. Orthopedic Surgery
  - 10.3.1.1. Joint Replacement
    - 10.3.1.1.1. Hip Replacement
    - 10.3.1.1.2. Knee Replacement
    - 10.3.1.1.3. Shoulder Replacement
    - 10.3.1.1.4. Small Bone Replacement
- 10.3.2. Orthopedic Oncology
10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
- 11.3.1. Web Based Software
- 11.3.2. Cloud Based Software
- 11.3.3. On Premises
11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 12.3.1. Hospitals
- 12.3.2. Ambulatory Surgical Centres
- 12.3.3. Orthopedic Office-Based
- 12.3.4. Clinics
12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 14.4.1. By Country
  - 14.4.1.1. U.S.
  - 14.4.1.2. Canada
- 14.4.2. By Solution
- 14.4.3. By Application
- 14.4.4. By Deployment
- 14.4.5. By End User
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Solution
- 14.5.3. By Application
- 14.5.4. By Deployment
- 14.5.5. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 15.4.1. By Country
  - 15.4.1.1. Brazil
  - 15.4.1.2. Mexico
  - 15.4.1.3. Rest of Latin America
- 15.4.2. By Solution
- 15.4.3. By Application
- 15.4.4. By Deployment
- 15.4.5. By End User
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Solution
- 15.5.3. By Application
- 15.5.4. By Deployment
- 15.5.5. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 16.4.1. By Country
  - 16.4.1.1. Germany
  - 16.4.1.2. Italy
  - 16.4.1.3. France
  - 16.4.1.4. U.K.
  - 16.4.1.5. Spain
  - 16.4.1.6. BENELUX
  - 16.4.1.7. Russia
  - 16.4.1.8. Rest of Europe
- 16.4.2. By Solution
- 16.4.3. By Application
- 16.4.4. By Deployment
- 16.4.5. By End User
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Solution
- 16.5.3. By Application
- 16.5.4. By Deployment
- 16.5.5. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 17.4.1. By Country
  - 17.4.1.1. India
  - 17.4.1.2. ASEAN
  - 17.4.1.3. Oceania
  - 17.4.1.4. Rest of South Asia & Pacific
- 17.4.2. By Solution
- 17.4.3. By Application
- 17.4.4. By Deployment
- 17.4.5. By End User
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Solution
- 17.5.3. By Application
- 17.5.4. By Deployment
- 17.5.5. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 18.4.1. By Country
  - 18.4.1.1. China
  - 18.4.1.2. Japan
  - 18.4.1.3. South Korea
- 18.4.2. By Solution
- 18.4.3. By Application
- 18.4.4. By Deployment
- 18.4.5. By End User
18.5. Market Attractiveness Analysis
- 18.5.1. By Country
- 18.5.2. By Solution
- 18.5.3. By Application
- 18.5.4. By Deployment
- 18.5.5. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 19.4.1. By Country
  - 19.4.1.1. Australia
  - 19.4.1.2. New Zealand
- 19.4.2. By Solution
- 19.4.3. By Application
- 19.4.4. By Deployment
- 19.4.5. By End User
19.5. Market Attractiveness Analysis
- 19.5.1. By Country
- 19.5.2. By Solution
- 19.5.3. By Application
- 19.5.4. By Deployment
- 19.5.5. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
- 20.4.1. By Country
  - 20.4.1.1. GCC Countries
  - 20.4.1.2. Turkey
  - 20.4.1.3. Northern Africa
  - 20.4.1.4. South Africa
  - 20.4.1.5. Rest of Middle East and Africa
- 20.4.2. By Solution
- 20.4.3. By Application
- 20.4.4. By Deployment
- 20.4.5. By End User
20.5. Market Attractiveness Analysis
- 20.5.1. By Country
- 20.5.2. By Solution
- 20.5.3. By Application
- 20.5.4. By Deployment
- 20.5.5. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

21.1. Introduction
- 21.1.1. Market Value Proportion Analysis
- 21.1.2. Global VS. Country Growth Comparison
- 21.1.3. Pricing Analysis, by Country
21.2. U.S. Orthopedic Planning Systems Market Analysis
- 21.2.1. By Solution
- 21.2.2. By Application
- 21.2.3. By Deployment
- 21.2.4. By End User
21.3. Canada Orthopedic Planning Systems Market Analysis
- 21.3.1. By Solution
- 21.3.2. By Application
- 21.3.3. By Deployment
- 21.3.4. By End User
21.4. Mexico Orthopedic Planning Systems Market Analysis
- 21.4.1. By Solution
- 21.4.2. By Application
- 21.4.3. By Deployment
- 21.4.4. By End User
21.5. Brazil Orthopedic Planning Systems Market Analysis
- 21.5.1. By Solution
- 21.5.2. By Application
- 21.5.3. By Deployment
- 21.5.4. By End User
21.6. Germany Orthopedic Planning Systems Market Analysis
- 21.6.1. By Solution
- 21.6.2. By Application
- 21.6.3. By Deployment
- 21.6.4. By End User
21.7. Italy Orthopedic Planning Systems Market Analysis
- 21.7.1. By Solution
- 21.7.2. By Application
- 21.7.3. By Deployment
- 21.7.4. By End User
21.8. France Orthopedic Planning Systems Market Analysis
- 21.8.1. By Solution
- 21.8.2. By Application
- 21.8.3. By Deployment
- 21.8.4. By End User
21.9. U.K. Orthopedic Planning Systems Market Analysis
- 21.9.1. By Solution
- 21.9.2. By Application
- 21.9.3. By Deployment
- 21.9.4. By End User
21.10. Spain Orthopedic Planning Systems Market Analysis
- 21.10.1. By Solution
- 21.10.2. By Application
- 21.10.3. By Deployment
- 21.10.4. By End User
21.11. Russia Orthopedic Planning Systems Market Analysis
- 21.11.1. By Solution
- 21.11.2. By Application
- 21.11.3. By Deployment
- 21.11.4. By End User
21.12. China Orthopedic Planning Systems Market Analysis
- 21.12.1. By Solution
- 21.12.2. By Application
- 21.12.3. By Deployment
- 21.12.4. By End User
21.13. Japan Orthopedic Planning Systems Market Analysis
- 21.13.1. By Solution
- 21.13.2. By Application
- 21.13.3. By Deployment
- 21.13.4. By End User
21.14. S. Korea Orthopedic Planning Systems Market Analysis
- 21.14.1. By Solution
- 21.14.2. By Application
- 21.14.3. By Deployment
- 21.14.4. By End User
21.15. India Orthopedic Planning Systems Market Analysis
- 21.15.1. By Solution
- 21.15.2. By Application
- 21.15.3. By Deployment
- 21.15.4. By End User
21.16. ASEAN Orthopedic Planning Systems Market Analysis
- 21.16.1. By Solution
- 21.16.2. By Application
- 21.16.3. By Deployment
- 21.16.4. By End User
21.17. Australia Orthopedic Planning Systems Market Analysis
- 21.17.1. By Solution
- 21.17.2. By Application
- 21.17.3. By Deployment
- 21.17.4. By End User
21.18. New Zealand Orthopedic Planning Systems Market Analysis
- 21.18.1. By Solution
- 21.18.2. By Application
- 21.18.3. By Deployment
- 21.18.4. By End User
21.19. Turkey Orthopedic Planning Systems Market Analysis
- 21.19.1. By Solution
- 21.19.2. By Application
- 21.19.3. By Deployment
- 21.19.4. By End User
21.20. South Africa Orthopedic Planning Systems Market Analysis
- 21.20.1. By Solution
- 21.20.2. By Application
- 21.20.3. By Deployment
- 21.20.4. By End User

22. Market Structure Analysis

22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
- 22.3.1. By Regional footprint of Players
- 22.3.2. Device foot print by Players
- 22.3.3. Channel Foot Print by Players

23. Competition Analysis

23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
- 23.3.1. Formus Labs Ltd
  - 23.3.1.1. Overview & Key financials
  - 23.3.1.2. Product Portfolio
  - 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.1.4. SWOT Analysis
  - 23.3.1.5. Sales Footprint
  - 23.3.1.6. Strategy Overview
  - 23.3.1.7. Sales and Marketing strategies
  - 23.3.1.8. Channel Strategies
- 23.3.2. EOS imaging
  - 23.3.2.1. Overview & Key financials
  - 23.3.2.2. Product Portfolio
  - 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.2.4. SWOT Analysis
  - 23.3.2.5. Sales Footprint
  - 23.3.2.6. Strategy Overview
  - 23.3.2.7. Sales and Marketing strategies
  - 23.3.2.8. Channel Strategies
- 23.3.3. Brainlab AG
  - 23.3.3.1. Overview & Key financials
  - 23.3.3.2. Product Portfolio
  - 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.3.4. SWOT Analysis
  - 23.3.3.5. Sales Footprint
  - 23.3.3.6. Strategy Overview
  - 23.3.3.7. Sales and Marketing strategies
  - 23.3.3.8. Channel Strategies
- 23.3.4. Sectra AB
  - 23.3.4.1. Overview & Key financials
  - 23.3.4.2. Product Portfolio
  - 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.4.4. SWOT Analysis
  - 23.3.4.5. Sales Footprint
  - 23.3.4.6. Strategy Overview
  - 23.3.4.7. Sales and Marketing strategies
  - 23.3.4.8. Channel Strategies
- 23.3.5. Stryker
  - 23.3.5.1. Overview & Key financials
  - 23.3.5.2. Product Portfolio
  - 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.5.4. SWOT Analysis
  - 23.3.5.5. Sales Footprint
  - 23.3.5.6. Strategy Overview
  - 23.3.5.7. Sales and Marketing strategies
  - 23.3.5.8. Channel Strategies
- 23.3.6. Materialise
  - 23.3.6.1. Overview & Key financials
  - 23.3.6.2. Product Portfolio
  - 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.6.4. SWOT Analysis
  - 23.3.6.5. Sales Footprint
  - 23.3.6.6. Strategy Overview
  - 23.3.6.7. Sales and Marketing strategies
  - 23.3.6.8. Channel Strategies
- 23.3.7. Medstrat
  - 23.3.7.1. Overview & Key financials
  - 23.3.7.2. Product Portfolio
  - 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.7.4. SWOT Analysis
  - 23.3.7.5. Sales Footprint
  - 23.3.7.6. Strategy Overview
  - 23.3.7.7. Sales and Marketing strategies
  - 23.3.7.8. Channel Strategies
- 23.3.8. MediCAD Hectec GmbH
  - 23.3.8.1. Overview & Key financials
  - 23.3.8.2. Product Portfolio
  - 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.8.4. SWOT Analysis
  - 23.3.8.5. Sales Footprint
  - 23.3.8.6. Strategy Overview
  - 23.3.8.7. Sales and Marketing strategies
  - 23.3.8.8. Channel Strategies
- 23.3.9. 3D Systems, Inc
  - 23.3.9.1. Overview & Key financials
  - 23.3.9.2. Product Portfolio
  - 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.9.4. SWOT Analysis
  - 23.3.9.5. Sales Footprint
  - 23.3.9.6. Strategy Overview
  - 23.3.9.7. Sales and Marketing strategies
  - 23.3.9.8. Channel Strategies
- 23.3.10. PEEK HEALTH S.A
  - 23.3.10.1. Overview & Key financials
  - 23.3.10.2. Product Portfolio
  - 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.10.4. SWOT Analysis
  - 23.3.10.5. Sales Footprint
  - 23.3.10.6. Strategy Overview
  - 23.3.10.7. Sales and Marketing strategies
  - 23.3.10.8. Channel Strategies
- 23.3.11. Radlink, Inc.
  - 23.3.11.1. Overview & Key financials
  - 23.3.11.2. Product Portfolio
  - 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.11.4. SWOT Analysis
  - 23.3.11.5. Sales Footprint
  - 23.3.11.6. Strategy Overview
  - 23.3.11.7. Sales and Marketing strategies
  - 23.3.11.8. Channel Strategies
- 23.3.12. SurgiNovi
  - 23.3.12.1. Overview & Key financials
  - 23.3.12.2. Product Portfolio
  - 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.12.4. SWOT Analysis
  - 23.3.12.5. Sales Footprint
  - 23.3.12.6. Strategy Overview
  - 23.3.12.7. Sales and Marketing strategies
  - 23.3.12.8. Channel Strategies
- 23.3.13. RSA Biomedical
  - 23.3.13.1. Overview & Key financials
  - 23.3.13.2. Product Portfolio
  - 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.13.4. SWOT Analysis
  - 23.3.13.5. Sales Footprint
  - 23.3.13.6. Strategy Overview
  - 23.3.13.7. Sales and Marketing strategies
  - 23.3.13.8. Channel Strategies
- 23.3.14. HIPOP-PLAN
  - 23.3.14.1. Overview & Key financials
  - 23.3.14.2. Product Portfolio
  - 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.14.4. SWOT Analysis
  - 23.3.14.5. Sales Footprint
  - 23.3.14.6. Strategy Overview
  - 23.3.14.7. Sales and Marketing strategies
  - 23.3.14.8. Channel Strategies
- 23.3.15. Zimmer Biomet.
  - 23.3.15.1. Overview & Key financials
  - 23.3.15.2. Product Portfolio
  - 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.15.4. SWOT Analysis
  - 23.3.15.5. Sales Footprint
  - 23.3.15.6. Strategy Overview
  - 23.3.15.7. Sales and Marketing strategies
  - 23.3.15.8. Channel Strategies
- 23.3.16. Optinav
  - 23.3.16.1. Overview & Key financials
  - 23.3.16.2. Product Portfolio
  - 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.16.4. SWOT Analysis
  - 23.3.16.5. Sales Footprint
  - 23.3.16.6. Strategy Overview
  - 23.3.16.7. Sales and Marketing strategies
  - 23.3.16.8. Channel Strategies
- 23.3.17. Enhatch Inc.
  - 23.3.17.1. Overview & Key financials
  - 23.3.17.2. Product Portfolio
  - 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.17.4. SWOT Analysis
  - 23.3.17.5. Sales Footprint
  - 23.3.17.6. Strategy Overview
  - 23.3.17.7. Sales and Marketing strategies
  - 23.3.17.8. Channel Strategies
- 23.3.18. Numex GmbH
  - 23.3.18.1. Overview & Key financials
  - 23.3.18.2. Product Portfolio
  - 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.18.4. SWOT Analysis
  - 23.3.18.5. Sales Footprint
  - 23.3.18.6. Strategy Overview
  - 23.3.18.7. Sales and Marketing strategies
  - 23.3.18.8. Channel Strategies
- 23.3.19. Corin Group
  - 23.3.19.1. Overview & Key financials
  - 23.3.19.2. Product Portfolio
  - 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.3.19.4. SWOT Analysis
  - 23.3.19.5. Sales Footprint
  - 23.3.19.6. Strategy Overview
  - 23.3.19.7. Sales and Marketing strategies
  - 23.3.19.8. Channel Strategies